Chào mừng trở lại
Tham gia Cointime
Đăng nhập với email
Đăng nhập với
Đăng ký
Cross Atlantic Partners
About
Cross Atlantic Partners (CAP) actively manages private equity funds for investment in developing healthcare and life sciences companies in
- New York,New York,United States
- http://www.crossatlanticpartners.com
Details
- Founded date
- Jan 1, 1994
- Operating Status
- Active
- Legal Name
- Cross Atlantic Partners
- Also Known As
- CAP
- Investor Type
- PE,Venture Capital
Cross Atlantic Partners (CAP) actively manages private equity funds for investment in developing healthcare and life sciences companies in the United States. They focus on later-stage private and public companies developing innovative drug discovery tools, devices, and services for human healthcare.
Investments
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jan 8, 2013
Labcyte
|
Series D | $5.30M | Alternative Medicine | — |
|
Jun 7, 2010
QuesCom
|
Series Unknown | $2.99M | Internet | — |
|
Oct 14, 2008
Sapphire Digital
|
Series A | $4M | Health Care | — |
|
Mar 28, 2008
Mobile Digital Media
|
Series Unknown | $2M | Software | Yes |
|
Mar 28, 2008
|
Series Unknown | $2M | Gaming | — |
Employee Profiles
Exits
Cross Atlantic Partners has had 7 exits. Cross Atlantic Partners most notable exits include Sapphire Digital , Labcyte
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Sep 14, 2021 | Sapphire Digital | M&A | Health Care | Detail |
| Jan 30, 2019 | Labcyte | M&A | Alternative Medicine | Detail |
| Oct 3, 2016 | GQ Life Sciences | M&A | Health Care | Detail |
| Jan 21, 2014 | Confluent Surgical | M&A | Health Care | Detail |
| Nov 10, 2011 | Medivance | M&A | Biotechnology | Detail |
